Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Aims to Corner SNP-ermarket

Premium

Sequenom recently completed the largest known SNP validation study to date, adding 3,148 novel SNPs to the public domain. “The whole study was designed and confirmed in three and a half weeks,” says Toni Schuh, president and CEO.

Sequenom worked in collaboration with the National Cancer Institute, but the SNPs studied and validated were not specifically cancer-related. NCI funded assays and Sequenom paid for validation of the near-million-dollar project. “The advantage for us,” Schuh says, “is that we now have the assays for all these SNPs. These are all very high-value SNPs.”

Sequenom simultaneously developed its automated assay design engine, which was essential to designing more than 9,000 assays for the study and will be used in an upcoming 100,000-SNP project with Incyte.

The expense and effort involved in making the assays is a stumbling block for other companies, Schuh contends. “That’s something that people who want to play in large-scale genotyping easily forget about. It’s in fact very quickly a multimillion-dollar game,” he says.

Sequenom’s mass spectrometer technology is capable, with multiplexing, of processing 250,000 mass arrays each day, or even more by pooling DNA samples. “The bottleneck is not the detection anymore,” Schuh says — it’s doing the PCRs.

Based on its current technology advantage, Sequenom sees itself dominating the industry. Schuh predicts that when another study comes out and tops these numbers, “it’ll still be Sequenom.”

— Meredith Salisbury

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.